RANI
RANI
NASDAQ · Pharmaceuticals

Rani Therapeutics Holdings-A

$0.86
+0.01 (+1.22%)
As of Sep 20, 10:42 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +4,209.7% upside
Low Target $30.65
Average Target $37.15
High Target $44.71
Current Price $0.86
Current
$0.86
Target
$37.15
$30.65 $37.15 avg $44.71
Scenario Analysis
Bear Case
$30.65
3,455.7%
Low target
Base Case
$37.15
+4,209.7%
Avg target
Bull Case
$44.71
+5,086.8%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$3.87
-77.7% from high
52-Week Low
$0.45
+93.7% from low
Target vs 52W High
$37.15
+859.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%